.png){kind=icon}
.png){kind=icon}
Return
Treg Cells as Potential Therapeutic Targets for Bullous Pemphigoid: A review
.png){kind=icon}
PRE
AI
H
S
X
J
M
F
R
DOI：10.1016/j.jdermsci.2026.04.003.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Treg dysfunction is a key upstream mechanism disrupting immune tolerance in bullous pemphigoid. • Treg-targeted therapies, like low-dose IL-2 and adoptive Treg transfer, can restore immune balance. • Low-dose IL-2 shows promising efficacy and safety in a recent clinical trial for BP. • A defective PD-1 pathway impairs Treg function, linking it to spontaneous and drug-induced BP. • Treg therapies offer potential for durable remission with fewer side effects than broad immunosuppression.
Keywords:
Treg cells
Bullous pemphigoid
Immune tolerance
Low-dose IL-2
PD-1 pathway
Journal
IF:
4
Papers:
3.6K
Citations:
6.4K
Organization
No organization information available
Cited Papers